Heart and Blood Vessels: Provides cardiovascular protective effects
Acknowledgment The authors would like to thank medical writer Amy Ross, PhD, of PRECISION scientia for her assistance with reference gathering, outline development, and review of the draft and Sherif Mehanna, MD for providing a medical accuracy review
hypertension, type 2 DM, dyslipidemia) A meta-analysis of 22 trials involving over 17,000 patients determined that 50.2% and 17.5% of patients treated with GLP-1RAs (exenatide, semaglutide & liraglutide) experienced a weight loss of 5% and 10% compared to placebo, and that patients without type 2 diabetes achieved a significantly greater weight loss compared to those with diabetes (Vosoughi et al, 2022)
Additionally, the medication's effects on gut motility and the gastrointestinal microenvironment have not been extensively studied in the context of active intestinal inflammation
They are game-changers in appetite suppression and blood sugar management
This extended interval tests your ability to function without frequent GLP-1 support while maintaining a safety net
